SCHEMBL17188733

SCHEMBL17188733

O=C(CNc1nc(-c2cc(Cl)cc(Cl)c2F)cs1)N1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.40
▸ HPGD P15428 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ HSD11B1 P28845 1/20 0.40
▸ RORC P51449 2/20 0.39
▸ PTGS2 P35354 2/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ MAOB P27338 3/20 0.38
▸ MAOA P21397 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ FABP4 P15090 1/20 0.37
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988045 0.78 RAB9A (0.62) GAAHPGDMAPTALDH1A1RAB9A
SCHEMBL17188723 0.76 GAA (0.49) GAAHPGDMAPTALDH1A1RAB9A
SCHEMBL3179153 0.76 KMT2A (0.52) GAAHPGDMAPTALDH1A1RAB9A
SCHEMBL8459487 0.75 HPGD (0.53) GAAHPGDMAPTALDH1A1RAB9A
SCHEMBL8452347 0.73 KMT2A (0.52) GAAHPGDMAPTALDH1A1RAB9A
SCHEMBL17188766 0.71 KMT2A (0.57) HPGDMAPTALDH1A1PTGS2NPC1
Trifluoroacetic Acid SCHEMBL3171698 0.71 MMP2 (0.47) GAAHPGDMAPTALDH1A1RAB9A
Trifluoroacetic Acid SCHEMBL3173811 0.70 GAA (0.47) GAAHPGDMAPTALDH1A1RAB9A
Trifluoroacetic Acid SCHEMBL3179280 0.69 MMP2 (0.47) GAAHPGDMAPTALDH1A1RAB9A
SCHEMBL6828220 0.67 KMT2A (0.47) GAAHPGDMAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265606-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-10-21 — — EP disclosed
Send feedback